Section Arrow
Quote
RDY.NYSE
- Dr Reddy's Laboratories Limited
Quotes are at least 15-min delayed:2024/09/21 04:13 EDT
Last
 78.54
+0.19 (+0.24%)
Day High 
78.6 
Prev. Close
78.35 
1-M High
84.23 
Volume 
206.35K 
Bid
77.52
Ask
79.52
Day Low
77.957 
Open
78.46 
1-M Low
78.1 
Market Cap 
13.05B 
Currency USD 
P/E 19.66 
%Yield 0.61 
10-SMA 79.39 
20-SMA 80.75 
50-SMA 81.09 
52-W High 84.46 
52-W Low 63.72 
Exchange NYSE 
Valuation Estimation
EPS (Current/Estimated)
333.26/326.85
Enterprise Value
19.04B
Balance Sheet
Book Value Per Share
21.08
Cash Flow
Cash Flow Yield
0.04
Income Statement
Total Revenue
279.16B
Operating Revenue Per Share
19.25
Industry Comparison
More
Code Name   Last Change Change (%) P/E P/E Range
VTRSViatris11.39-0.51-4.29%227.2PE
TLRYTilray Brands1.71-0.07-3.93%-- 
TEVATeva Pharmaceutical Industries Limited17.51-0.25-1.41%-- 
ELANElanco Animal Health14.07-1-6.64%-- 
IRWDIronwood Pharmaceuticals4.305-0.205-4.55%56.38PE
Quotes are at least 15-min delayed：2024/09/21 04:13 EDT
Industry overview quotes are at least 15 minutes delayed
Business Description
Dr. Reddy's is one of the largest generic drug manufacturers in the world. It has a significant presence in North America, a region that makes up roughly half of its generics sales, and it services India (about 20% of its generics sales), Russia (10%), and certain European and Latin American countries. Beyond simple generics, Dr. Reddy's also has a solid portfolio of injectables which make up 25% of its North America sales. In branded generic markets like India, Dr. Reddy's has established a compelling presence with its strong brand name and earned a top five spot in key therapeutic areas including oncology and gastroenterology. Dr. Reddy's also has an active pharmaceutical ingredient business that manufactures over 150 APIs and sells in over 75 countries.
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.